Over the years, we have successfully helped hundreds
of sleep apnea patients pay no more for their funeral insurance compared to someone without it.
However, clinically significant depressive symptoms remained in only 4 percent
of the sleep apnea patients who adhered to CPAP therapy for 3 months (9 of 228 patients).
Results show that nearly 73 percent
of sleep apnea patients (213 of 293 patients) had clinically significant depressive symptoms at baseline, with a similar symptom prevalence between men and women.
That's why it is estimated that more than 40 percent
of sleep apnea patients refuse to wear the device.
Not exact matches
TORONTO, May 16, 2017 — An at - home
sleep apnea test will be available to Ontario
patients for the first time as the result
of a unique MaRS program.
But
sleep apnea patients are also more likely to suffer dangerous health problems, and they are at greater risk
of dying while they
sleep.
Physiologic studies also have shown that healthy infants are able to protect their airways and do not have increased
apnea when placed supine.20 Meyers and Herbst21 showed that the amount
of gastroesophageal reflux in healthy
patients was not significantly affected by changes in
sleep position.
«Until we have further evidence on the efficacy
of medical cannabis for the treatment
of sleep apnea, and until its safety profile is established,
patients should discuss proven treatment options with a licensed medical provider at an accredited
sleep facility,» said lead author Dr. Kannan Ramar, professor
of medicine in the division
of pulmonary and critical care medicine at Mayo Clinic in Rochester, Minnesota.
To investigate, researchers led by Roberto Pisoni, MD (Medical University
of South Carolina) analyzed information on 56
patients with diabetes and CKD who had undergone screening for obstructive
sleep apnea through the use
of a questionnaire.
«This study shows that a high - risk score for obstructive
sleep apnea is common in non-dialysis CKD
patients with diabetic nephropathy and is associated with more rapid loss
of renal function,» the investigators concluded.
To qualify,
patients must be an acceptable surgical risk and be defined as either severely obese with a BMI
of 40 or greater or have a BMI
of 35 or greater with at least one related condition: diabetes, obstructive
sleep apnea, obesity - related cardiomyopathy or heart muscle disease or severe joint disease.
«We believe that by treating or stopping obstructive
sleep apnea progression, we will not only improve
patients» quality
of life, but also delay health issues related to aging.»
More unexpected, researchers at the University
of Wisconsin at Madison uncovered a link between
sleep apnea and cancer mortality: Cancer deaths among
patients with severe
apnea were five times higher than among those without.
He also plans a multicenter / multinational study
of patients with melanoma or other types
of cancer, to examine the effect
of long - term CPAP therapy on those also diagnosed with
sleep apnea.
The researchers found that
patients diagnosed with the most aggressive cancers had higher prevalence and severity
of obstructive
sleep apnea.
In terms
of diagnosis, doctors and
patients may attribute daytime tiredness to «just being pregnant» rather than to
sleep apnea.
However, breathing abnormalities may not be the only reasons for increased risk
of complications — many
sleep apnea patients suffer from cardiovascular problems as well that may worsen surrounding surgery,» Dr. Memtsoudis explained.
«The high quality,
patient - centered care provided by board - certified
sleep medicine physicians can significantly reduce the health and economic burdens
of sleep apnea,» said AASM President Dr. Ronald Chervin.
A companion report was also released, titled «In an age
of constant activity, the solution to improving the nation's health may lie in helping it
sleep better,» which summarizes the results
of an online survey completed by
patients currently being treated for obstructive
sleep apnea (OSA).
Research led by the University
of Birmingham has discovered that
patients who suffer from both Type 2 diabetes and obstructive
sleep apnea are at greater risk
of developing a condition that leads to blindness within an average period
of less than four years.
The researchers identified 30,024
patients with
sleep apnea undergoing these procedures whose medical records included information on the type
of anesthesia used during the surgery.
«Since obstructive
sleep apnea is a treatable condition that is also commonly seen in MS, we wondered, «What if some
of the thinking and processing difficulties that MS
patients experience do not stem directly from the MS itself, but from the effects
of sleep apnea or other
sleep problems?»»
People with MS face an elevated risk
of obstructive
sleep apnea (OSA), a disorder in which the throat collapses during
sleep, causing the
patient to repeatedly stop breathing for periods
of 10 seconds or longer throughout the night.
In 2006, the ASA released guidelines recommending the use
of regional anesthesia, when possible, in
patients with
sleep apnea undergoing surgery to reduce the use
of systemic opioids.
To determine whether
sleep apnea is linked to the development
of pneumonia, Taiwanese researchers followed 34 100
patients (6816 who had
sleep apnea and 27 284 controls) for 11 years.
Many years ago clinicians began noticing that
patients with
sleep apnea were at an increased risk
of developing complications after operations.
Without favorable options to turn to and with the threat
of cardiovascular issues like high blood pressure and heart disease if
sleep apnea is left untreated, physicians and
patients» families are sometimes left with the difficult decision to resort to life - altering tracheostomies, if the obstruction is severe enough to be unsafe.
They also calculated that diagnosing and treating every
patient in the U.S. who has
sleep apnea would produce an annual economic savings
of $ 100.1 billion.
Now, the researchers will replicate their findings in a larger sample
of MS
patients, and treat those
patients diagnosed with obstructive
sleep apnea with positive airway pressure therapy (CPAP), the first - line treatment for OSA.
Obstructive
sleep apnea (OSA) is a condition where the walls
of the throat relax and narrow during
sleep, resulting in snoring and interrupting breathing, and it is common in
patients with Type 2 diabetes.
Current
apnea treatments, such as the use
of continuous positive airway pressure (C - PAP) while
sleeping, are difficult for many
patients to maintain and provide only limited benefits.
«This study, for the first time, shows that the use
of regional anesthesia improves outcomes in
patients with
sleep apnea undergoing total joint arthroplasty.
The companion report was based on a survey
of 506
patients who are currently being treated for obstructive
sleep apnea.
«Our results also demonstrated an exposure - response relation in that
patients with more severe
sleep apnea may have a higher risk
of pneumonia than
patients with
sleep apnea of milder severity.»
Currently, up to 25 %
of patients presenting for surgery in the United States have
sleep apnea.
It's also the first study to show the size
of the effect
of positive pressure mask treatment (CPAP) in
patients with obstructive
sleep apnea (OSAS) on their nocturia symptoms.»
Up to 50 %
of patients can't or won't wear a mask so their
sleep apnea is untreated or inadequately treated.»
In a landmark 2007 study, they performed tonsillectomies on 26 kids with OSA who showed signs
of vascular dysfunction; after the operations cured their
sleep apnea, arterial tissue returned to normal in 20
of the
patients.
Another recent study, published last week in the Journal
of Clinical
Sleep Medicine, found that as many as 94 percent of adults with Down's syndrome had some sort of obstructive sleep apnea — and in 69 percent of those patients it was se
Sleep Medicine, found that as many as 94 percent
of adults with Down's syndrome had some sort
of obstructive
sleep apnea — and in 69 percent of those patients it was se
sleep apnea — and in 69 percent
of those
patients it was severe.
Patients with chronic rhinosinusitis (sinus infection) and obstructive
sleep apnea report a poor quality
of life, which is substantially improved following endoscopic sinus surgery, according to a study published online by JAMA Otolaryngology - Head & Neck Surgery.
Timothy L. Smith, M.D., M.P.H.,
of Oregon Health & Science University, Portland, and colleagues investigated the impact
of comorbid obstructive
sleep apnea (OSA) on CRS disease - specific QOL and
sleep dysfunction in
patients with CRS following functional endoscopic sinus surgery (FESS).
Similarly, only half
of the
patients with OSA were categorized as being at high risk for OSA on the Berlin Questionnaire, a
sleep apnea screening tool, suggesting that these validated tools in the general population may not be useful for
patients with cardiovascular diseases.
«Based on our findings, future studies are warranted to evaluate the utility
of cardiopulmonary exercise testing for cardiovascular risk stratification in
patients with obstructive
sleep apnea.»
This can be done using a procedure called «drug - induced
sleep endoscopy» (DISE), in which stepwise doses
of anesthetic doses are given to put the
patient to
sleep and reproduce the airway obstruction causing
apnea.
Dr. Joshua H. Atkins and Dr. Jeff E. Mandel
of the University
of Pennsylvania and their colleagues have developed a new «ramp control» anesthetic technique for putting
patients to
sleep briefly - just enough to show the «obstructive anatomy» responsible for
sleep apnea.
In the largest study to date
of the relationship between
sleep apnea and diabetes, a new study
of more than 8,500 Canadian
patients has demonstrated a link between obstructive
sleep apnea (OSA) and the development
of diabetes, confirming earlier evidence
of such a relationship from smaller studies with shorter follow - up periods.
By simplifying the steps to anesthesia administration, the researchers believe their simplified approach will help to make DISE more widely available for evaluation
of patients being considered for
sleep apnea surgery.
Of the 1,000
patients included in this analysis, 60 percent were male and the average age was 61; 49 percent had cardiac disease, 41 percent diabetes, 30 percent chronic kidney disease and 17 percent
sleep apnea.
The researchers evaluated their anesthetic technique in 97
patients participating in a study
of robot - assisted surgery for severe
sleep apnea.
Total
apnea - hypopnea index (AHI)-- which measures severity
of sleep apnea by counting the number
of pauses in breathing during
sleep — for all
patients significantly decreased an average
of 35 events per hour after the device was planted, which corresponds to an average reduction
of 84 percent.